Also Launch of the Worlds Thinnest UHMWPE Fiber, Dyneema Purity 10 Dtex Fiber
DSMs Greenville, NC plant, dedicated for medical fiber manufacturing, begins production of the worlds thinnest, high-strength, medical-grade UHMWPE fiber, Dyneema Purity 10 dtex fiber
DSM, a global leader in biomedical materials science and regenerative medicine, today announced that the Companys Greenville, North Carolina facility is fully operational, running and qualified. Furthermore, DSM is expanding its Dyneema Purity fiber portfolio and is commercially launching the thinnest, high-strength, medical-grade UHMWPE fiber available on the market, Dyneema Purity 10 dtex fiber. The fiber will be available in both white and blue.
DSMs Greenville, NC facility demonstrates the Companys commitment to the medical market. It is the only plant of its kind dedicated solely to the production of medical-grade fibers. The site is ISO 13485:2003 certified, continuing DSMs longstanding tradition of maintaining facilities with quality management systems that consistently meet customer requirements and regulatory requirements applicable to medical device manufacturing and related services. In addition, the plant implements DSMs latest technological and environmental advances, which promote energy efficiency. Latest technology manufacturing processes result in lower emissions and support a much more efficient use of raw materials and processing techniques compared to standard plants.
Next to 10 dtex fibers, the Dyneema Purityfiber production line will produce various grades for cardiovascular applications, including Dyneema PurityTG 25 dtex fiber, which offers the same strength as existing grades at thinner diameters, and the Dyneema PuritySGX fibers. Dyneema PurityUG fibers will also be produced in Greenville, developed specifically to allow the development of strong, stable orthopedic implants that provide consistent performance.
Introducing Dyneema Purity 10 dtex fiber
Starting this month, DSM commercialized its Dyneema Purity10 dtex fiber and launched production exclusively at the Greenville, NC facility. The fiber is four times stronger than polyester and thinner than any other UHMWPE medical fiber on the market. The high quality manufacturing processes for the fiber benefit from the facilitys unique specialization in medical-grade manufacturing.
In 2012, the global minimally invasive surgery market was valued at approximately $25 billion and is expected to grow at a CAGR of 10.5% during the forecast period 2013 to 2019 to reach a market value of over $50 billion by 2019. Minimally invasive surgical procedures typically result in less discomfort and faster recovery times for patients. As such, medical device makers seek materials that enable the production and design of devices with tinier profiles. The Dyneema Purity10 dtex fibers fine denier promotes the design of smaller devices without compromising strength and durability.
The initial application of the material is in cardiovascular sutures, which will enablesurgeons to reach new patient groups with smaller or blocked veins and arteries. Other application focus areas include transcatheter heart valves (TAVI/TAVR systems) and Abdominal and Thoracic Aortic Aneurysm stent grafts.
Our Greenville, NC facility is focused on the manufacturing of medical-grade fiber and all of the technology implemented at the facility is proprietary to DSM and leverages our decades-long history of materials innovation, said Carola Hansen, Director of Biomedical Polyethylenes, DSM Biomedical. We are proud to bring to market our new Dyneema Purity 10 dtex fiber, the thinnest medical-grade material of its kind, and look forward toseeing it used by medical device manufacturers to innovate new technology that helps patients and surgeons.
For more information about DSMs Dyneema Purity fiber portfolio please visit:
DSM Bright Science. Brighter Living.
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSMs 23,500 employees deliver annual net sales of around 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.